Loading…
Loading…
CYBN (Cybin Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| ALEC | Alector, Inc. | $2.37 | $263.1M |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $13.42 | $213.9M |
| IPHA | Innate Pharma S.A. | $2.26 | $212.2M |
| PEPG | PepGen Inc. | $3.03 | $209.6M |
| NKTX | Nkarta, Inc. | $2.77 | $198.2M |
| MOLN | Molecular Partners AG | $4.67 | $175.2M |
| MIST | Milestone Pharmaceuticals Inc. | $1.18 | $146.9M |
| IMDX | Insight Molecular Diagnostics Inc. | $4.29 | $138.5M |
| SAVA | Cassava Sciences, Inc. | $1.32 | $63.8M |
| RANI | Rani Therapeutics Holdings, Inc. | $0.85 | $55.6M |